Company intelligence / Profile preview

Perseus Biomics

Kortenaken / Leuven area, Flemish Brabant, Belgiumperseusbiomics.com ↗

Ownership: Private
Development stage: Commercial

Overview

Perseus Biomics has developed the MetaMAP device powered by DynaMAP technology for high-resolution, strain-level microbiome profiling. Their service delivers actionable results within 5 days. The platform is validated for sensitivity and specificity in real-world applications across healthcare, nutrition, R&D, and regulatory compliance.

Therapeutic areas: Other
Modalities: DeviceMicrobial therapy (enabling technology for microbiome-based research and applications)
Industry: Molecular Diagnostics

Partnerships

ZEISS Group (strategic investment & technology collaboration)

Beyond the preview

Go deeper on Perseus Biomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perseus Biomics.

Explore the full profile